AI Science Tracker
EN

A multicenter explainable machine learning analysis of autoimmune disease comorbidity in ankylosing spondylitis.

Affiliation not stated in the reviewed material · 26 Feb 2026 · medicine

Discovery

A multicenter explainable machine learning analysis of autoimmune disease comorbidity in ankylosing spondylitis.

Source check: Source checked. Not independent scientific confirmation.

Finding: Methods 2.1: multicenter retrospective cross-sectional cohorts from three tertiary centers (2012–2025); two classification tasks, LightGBM and SHAP. Results: stable model performance and feature differences; systemic inflammatory/metabolic phenotype is an association, not prospective early detection. Learned LightGBM classification and SHAP produce clinical comorbidity classification and feature attribution; retrospective claims only. Testing: Methods 2.1: multicenter retrospective cross-sectional cohorts from three tertiary centers (2012–2025); two classification tasks, LightGBM and SHAP. Results: stable model performance and feature differences; systemic inflammatory/metabolic phenotype is an association, not prospective early detection.. Source affiliation was not stated in the reviewed case checks and was unavailable in the local bibliographic cache.

Technology: Learned LightGBM classification and SHAP produce clinical comorbidity classification and feature attribution; retrospective claims only.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Learned LightGBM classification and SHAP produce clinical comorbidity classification and feature attribution; retrospective claims only.
Test and result
Methods 2.1: multicenter retrospective cross-sectional cohorts from three tertiary centers (2012–2025); two classification tasks, LightGBM and SHAP. Results: stable model performance and feature differences; systemic inflammatory/metabolic phenotype is an association, not prospective early detection.
Limitation / still unknown
Methods 2.1: multicenter retrospective cross-sectional cohorts from three tertiary centers (2012–2025); two classification tasks, LightGBM and SHAP. Results: stable model performance and feature differences; systemic inflammatory/metabolic phenotype is an association, not prospective early detection.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1775877/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.